Glucose responses to Sustacal were similar after both formulations of glipizide ; however , serum insulin ( P < 0.01 ) and C-peptide responses ( P < 0.05 ) were lower with glipizide-GITS than with immediate-release glipizide treatment at the end of the 8-week treatment phase .
